Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection. What will really matter in the long run? That’s the question we tackle each year as ...
These AI-powered enterprise software giants saw pullbacks in their stock prices, but only one is worth buying right now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results